Abstract | BACKGROUND: METHODS AND RESULTS: We measured plasma levels of sFas and TNF-alpha and those of atrial natriuretic peptide ( ANP), brain natriuretic peptide (BNP), norepinephrine, and endothelin 1 in 96 patients with CHF (ejection fraction < 45%). The patients were monitored for 3 years. Plasma levels of sFas and TNF-alpha increased with the severity of CHF. There was no significant correlation between sFas plasma levels and those of ANP and BNP. Cox proportional hazard analysis showed that high levels of sFas (P = .009) and BNP (P < .0001) and a low ejection fraction (P = .019) were independent significant prognostic predictors. CONCLUSIONS: There is no significant correlation between cardiac natriuretic peptide and sFas levels in plasma. Plasma sFas is a useful prognostic marker independent of neurohumoral factors, suggesting that immune activation and/or apoptosis play a significant role in the pathogenesis of CHF.
|
Authors | T Tsutamoto, A Wada, K Maeda, N Mabuchi, M Hayashi, T Tsutsui, M Ohnishi, M Fujii, T Matsumoto, T Yamamoto, T Takayama, M Kinoshita |
Journal | Journal of cardiac failure
(J Card Fail)
Vol. 7
Issue 4
Pg. 322-8
(Dec 2001)
ISSN: 1071-9164 [Print] United States |
PMID | 11782855
(Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Endothelin-1
- Tumor Necrosis Factor-alpha
- fas Receptor
- Natriuretic Peptide, Brain
- Atrial Natriuretic Factor
- Norepinephrine
|
Topics |
- Age Factors
- Aged
- Apoptosis
- Atrial Natriuretic Factor
(blood)
- Biomarkers
(blood)
- Endothelin-1
(blood)
- Female
- Follow-Up Studies
- Heart Failure
(blood, diagnosis, mortality)
- Humans
- Japan
- Male
- Middle Aged
- Natriuretic Peptide, Brain
(blood)
- Norepinephrine
(blood)
- Predictive Value of Tests
- Prognosis
- Severity of Illness Index
- Solubility
- Stroke Volume
(physiology)
- Survival Analysis
- Tumor Necrosis Factor-alpha
(metabolism)
- fas Receptor
(blood)
|